Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome

被引:0
|
作者
Safranko, Zeljka Macak [1 ]
Jakopec, Lana [1 ]
Svagusa, Karla [1 ]
Krajinovic, Lidija Cvetko [1 ]
Tomasovic, Domagoj [1 ]
Lukic, Ljiljana [1 ]
Markotic, Alemka [1 ,2 ,3 ]
机构
[1] Univ Hosp Infect Dis Dr Fran Mihaljev, Res Unit, Zagreb 10000, Croatia
[2] Univ Rijeka, Fac Med, Rijeka 51000, Croatia
[3] Catholic Univ Croatia, Fac Med, Zagreb 10000, Croatia
来源
LIFE-BASEL | 2024年 / 14卷 / 05期
关键词
orthohantavirus; HFRS; PUUV; inhibitory receptors; immune regulations; TIM-3; LAG-3; PD-1; T-CELL EXHAUSTION; INHIBITORY RECEPTORS; EXPRESSION; VIRUS; PROTEIN; HANTAVIRUSES; ACTIVATION; MACROPHAGE; AUTOIMMUNE; RESPONSES;
D O I
10.3390/life14050551
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hemorrhagic fever with renal syndrome (HFRS) is a rodent-borne disease widespread in Europe and Asia. HFRS is caused by negative-sensed single-stranded RNA orthohantaviruses transmitted to humans through inhaling aerosolized excreta of infected rodents. Symptoms of HFRS include acute kidney injury, thrombocytopenia, hemorrhages, and hypotension. The immune response raised against viral antigens plays an important role in the pathogenesis of HFRS. Inhibitory co-receptors are essential in regulating immune responses, mitigating immunopathogenesis, and reducing tissue damage. Our research showed an increased soluble form of inhibitory co-receptors TIM-3, LAG-3, and PD-1 in HFRS patients associated with disease severity. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and the potential correlation with key clinical parameters. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and their possible association with relevant clinical parameters. Using multiplex immunoassay, we found elevated levels of TIM-3, LAG-3, and PD-1 proteins in the serum of HFRS patients. Furthermore, increased levels were associated with creatinine, urea, lactate dehydrogenase concentrations, and platelet count. These findings suggest that these proteins play a role in regulating the immune response and disease progression.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy
    Kimiharu Takamatsu
    Nobuyuki Tanaka
    Kyohei Hakozaki
    Ryohei Takahashi
    Yu Teranishi
    Tetsushi Murakami
    Ryohei Kufukihara
    Naoya Niwa
    Shuji Mikami
    Toshiaki Shinojima
    Takashi Sasaki
    Yusuke Sato
    Haruki Kume
    Seishi Ogawa
    Kazuhiro Kakimi
    Takashi Kamatani
    Fuyuki Miya
    Tatsuhiko Tsunoda
    Eriko Aimono
    Hiroshi Nishihara
    Kazuaki Sawada
    Takeshi Imamura
    Ryuichi Mizuno
    Mototsugu Oya
    Nature Communications, 12
  • [22] Plasma levels of soluble PD-1, TIM-3, LAG-3 and galectin-3 and the degree of liver fibrosis in CHC and the impact of successful antiviral treatment on their levels
    Sylwia Osuch
    Aleksandra Kumorek
    Paweł Kozłowski
    Hanna Berak
    Anna Maria Kochanowicz
    Kamila Cortés-Fendorf
    Scientific Reports, 15 (1)
  • [23] Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer-T cell coculture models
    Mimura, Kosaku
    Kua, Ley-Fang
    Xiao, Jin-Fen
    Asuncion, Bernadette Reyna
    Nakayama, Yuko
    Syn, Nicholas
    Fazreen, Zul
    Soong, Richie
    Kono, Koji
    Yong, Wei-Peng
    GASTRIC CANCER, 2021, 24 (03) : 611 - 623
  • [24] Monoclonal antibodies targeting PD-1, LAG-3, and TIM-3 do not cause reproductive or endocrine toxicity in a syngeneic model of triple negative breast cancer
    De La Cruz, Payton
    Ribeiro, Jennifer
    Grive, Kathryn
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome
    Ciraolo, Elisa
    Althoff, Stefanie
    Russ, Josefine
    Rosnev, Stanislav
    Butze, Monique
    Puhl, Miriam
    Frentsch, Marco
    Bullinger, Lars
    Na, Il-Kang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [26] Role of PD-1 and LAG-3 in cancer immunotherapy.
    Drake, Charles G.
    CANCER RESEARCH, 2013, 73
  • [27] LAG-3 and PD-1 blockade raises the bar for melanoma
    Robert, Caroline
    NATURE CANCER, 2021, 2 (12) : 1251 - 1253
  • [28] Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
    Saleh, Reem
    Toor, Salman M.
    Khalaf, Sarah
    Elkord, Eyad
    VACCINES, 2019, 7 (04)
  • [29] Combined Immunotherapy for Melanoma: inhibit PD-1 and LAG-3
    Freyer, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (10) : 446 - 446
  • [30] LAG-3 and PD-1 blockade raises the bar for melanoma
    Caroline Robert
    Nature Cancer, 2021, 2 : 1251 - 1253